Farms.com Home   News

One Day, Plants Could Grow Your Meds, Say U of G Researchers

“Is this insulin animal-free?” 

In a future where major medications – like insulin, cancer treatments and life-saving vaccines – are grown from plants, such a question is valid. 

Though the Canadian Food Inspection Agency has said, “There is no commercial plant molecular farming in Canada to date, and none is anticipated in the near future,” University of Guelph researchers disagree

As Dr. Jennifer Geddes-McAlister, professor in the College of Biological Science puts it, there is no reason plants should not be making our drugs right now:

“In theory, it should already be happening,” she says. “Because the promise is there. The setup and infrastructure are there. The research is there. The biggest hurdle is reducing variability in drug production.”

These are the current aims of molecular pharming, the field that uses plants, rather than costly animal cells and materials, to produce our pharmaceuticals.

Click here to see more...

Trending Video

What’s at Stake in Every Slice | On The Brink: Episode 7

Video: What’s at Stake in Every Slice | On The Brink: Episode 7

Six hundred Canadian farms grow grain for Warburton's under custom contract — and that partnership exists because of Canadian plant breeding. Now the man responsible for maintaining it is sounding the alarm.

Adam Dyck is the program manager for Warburton's Canada, a company that produces over two million loaves of bread a day for more than 20,000 retail locations across the UK. He's watched Canadian wheat deliver thirty years of yield gains and quality advancements that make it worth sourcing at scale — and shipping across the Atlantic. But he's also watching the investment conditions that produced those gains come under pressure. Dyck makes the case for a new funding mechanism that brings both public and private dollars into wheat breeding before Canada's competitive window starts to close.